Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ICCM
ICCM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ICCM News
IceCure Expands in Brazil's Oncology Market with ProSense™
2d ago
PRnewswire
IceCure Medical Regains Nasdaq Compliance with Share Price Surge
Jun 25 2026
seekingalpha
IceCure Medical Regains Nasdaq Compliance
Jun 25 2026
PRnewswire
Pulsenmore Soars 280% on Ouma Health Collaboration
Jun 25 2026
NASDAQ.COM
IceCure Medical Highlights Cryoablation Study in Top Surgical Journal
Jun 23 2026
PRnewswire
IceCure Medical Completes Private Placement Financing
Jun 17 2026
PRnewswire
IceCure Medical Completes Private Placement Financing
Jun 17 2026
Newsfilter
IceCure Medical Receives FDA Authorization, Shares Surge 200%
Jun 17 2026
stocktwits
NeOnc Technologies Secures International Drug Authorization for NEO212
Jun 17 2026
Newsfilter
IceCure Medical Sees Significant Growth Post FDA Approval
Jun 17 2026
PRnewswire
IceCure Medical Sees Surge in ProSense® System Demand Following FDA Approval
Jun 17 2026
Newsfilter
IceCure Medical Announces 1-for-30 Reverse Stock Split
Jun 02 2026
seekingalpha
IceCure Medical Implements Reverse Split to Regain Nasdaq Compliance
Jun 02 2026
PRnewswire
IceCure Medical Implements Reverse Split to Regain Nasdaq Compliance
Jun 02 2026
Newsfilter
Breakthrough in Tumor Treatment with Cryoablation Technology
May 19 2026
PRnewswire
IceCure Medical Receives 180-Day Nasdaq Compliance Extension
May 13 2026
seekingalpha
Show More News
